ENTERA BIO LTD ENTX
SHS · Common Stock · CUSIP M40527109
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 36.8m as of 2024-11-04, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $1.90. Options: 4 managers hold calls ($5.7k notional), 2 hold puts ($190).
Trends to Q3 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 10 |
| Q4 2022 | 13 |
| Q1 2023 | 10 |
| Q2 2023 | 13 |
| Q3 2023 | 13 |
| Q4 2023 | 11 |
| Q1 2024 | 16 |
| Q2 2024 | 16 |
| Q3 2024 | 18 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 6 | 2 |
| Q1 2023 | 1 | 6 |
| Q2 2023 | 7 | 3 |
| Q3 2023 | 6 | 6 |
| Q4 2023 | 5 | 5 |
| Q1 2024 | 10 | 3 |
| Q2 2024 | 7 | 8 |
| Q3 2024 | 6 | 4 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q4 2023 | $24.6k | $0 | 0.00 |
| Q1 2024 | $6.5k | $0 | 0.00 |
| Q2 2024 | $736 | $0 | 0.00 |
| Q3 2024 | $5.7k | $190 | 0.03 |
Biggest buyers
| SIGNATURE ESTATE & INVESTMENT ADVISORS LLC | New | +47.3k |
| CITADEL ADVISORS LLC | New | +20.6k |
| Parkman Healthcare Partners LLC | Added | +9.6k |
| BANK OF AMERICA CORP /DE/ | Added | +5.4k |
| RENAISSANCE TECHNOLOGIES LLC | Added | +3.6k |
| JPMORGAN CHASE & CO | New | +4 |
Biggest sellers
| UBS Group AG | Reduced | -24.9k |
| Schonfeld Strategic Advisors LLC | Reduced | -23.2k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | -8.2k |
| SIMPLEX TRADING, LLC | Sold out | -260 |
Biggest calls
| CITADEL ADVISORS LLC | New | $4.9k2.6k shares |
| GROUP ONE TRADING LLC | Unchanged | $760400 shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
| SIMPLEX TRADING, LLC | Reduced | $0300 shares |
Biggest puts
| CITADEL ADVISORS LLC | New | $190100 shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
BIOTECHNOLOGY VALUE FUND L P
13D · may seek influence
new · filed 2026-08-04
Stated purposeThe Reporting Persons purchased the securities reported owned herein based on the Reporting Persons' belief that such securities, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable. April Securities Purchase Agreement and Registration Rights Agreement On April 1, 2026, … Full filing |
10.0% |
| OPKO HEALTH, INC. 13G · passive investor new · filed 2025-04-02 | 8.1% |
| TCG Crossover GP III, LLC 13G · passive investor new · filed 2026-08-04 | 7.1% |
| Vivo Opportunity Fund Holdings, L.P. 13G · passive investor new · filed 2026-08-04 | 6.9% |
Fell to 5% or below in the last year: Longitude Capital Partners V, LLC (4.6%, 2026-08-04), Seven Fleet Capital Management LP (4.1%, 2026-08-04)
Insider purchases and sales in Q3 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2022 | 4 | $100.8k | 0 | — | — |
| Q1 2023 | 0 | — | 0 | — | — |
| Q2 2023 | 1 | $30.3k | 0 | — | — |
| Q3 2023 | 3 | $47.0k | 0 | — | — |
| Q4 2023 | 2 | $17.0k | 0 | — | — |
| Q1 2024 | 1 | $15.3k | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
| Q3 2024 | 0 | — | 0 | — | — |
None reported in Q3 2024.
Holders, Q3 2024
| Manager | Shares | Change |
|---|---|---|
| Knoll Capital Management, LLC 3.42% of their portfolio | 3.9m $7.4m | Unchanged |
| Schonfeld Strategic Advisors LLC 0.01% of their portfolio | 648.6k $1.2m | Reduced -23.2k |
| Parkman Healthcare Partners LLC 0.10% of their portfolio | 411.1k $781.0k | Added +9.6k |
| UBS Group AG 0.00% of their portfolio | 142.7k $271.2k | Reduced -24.9k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 61.2k $116.3k | Added +3.6k |
| SIGNATURE ESTATE & INVESTMENT ADVISORS LLC 0.00% of their portfolio | 47.3k $89.9k | New |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 20.7k $39.2k | Reduced -8.2k |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 20.6k $39.1k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 17.6k $33.4k | Unchanged |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 16.8k $30.2k | Unchanged |
| PNC Financial Services Group, Inc. 0.00% of their portfolio | 13.0k $24.7k | Unchanged |
| CIBC WORLD MARKET INC. 0.00% of their portfolio | 12.5k $24.0k | Unchanged |
| HighTower Advisors, LLC 0.00% of their portfolio | 11.8k $22.0k | Unchanged |
| NewEdge Advisors, LLC 0.00% of their portfolio | 9.0k $17.1k | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 8.4k $16.0k | Added +5.4k |
| GROUP ONE TRADING LLC 0.00% of their portfolio | 51 $97 | Unchanged |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 4 $8 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |